Dalrada Health works to solve health problems around the world and is committed to developing products and services that address the unmet needs of consumers due to accessibility, availability, or affordability.
With operations in the U.S., Malaysia, and India, the company is able to reach underserved markets through strong partnerships and efficient supply chains.
Based on the World Health Organization’s recommended procedure for conducting visual inspection with acetic acid (VIA). Dalrada Health has developed a specialized kit that can detect tissue abnormalities.
Dalrada Health works to solve health problems around the world and is committed to developing products and services that address the unmet needs of consumers due to accessibility, availability, or affordability.
With operations in the U.S., Malaysia, and India, the company is able to reach underserved markets through strong partnerships and efficient supply chains.
INNOVATIVE
SOLUTIONS
DALRADA
HEALTH PRODUCTS
In many developed countries, the annual incidence and mortality rates from cervical cancer have been reduced by 50-70% since the introduction of simple population-based screening.
DALRADA
HEALTH PRODUCTS
In many developed countries, the annual incidence and mortality rates from cervical cancer have been reduced by 50-70% since the introduction of simple population-based screening.
Based on the World Health Organization’s recommended procedure for conducting visual inspection with acetic acid (VIA). Dalrada Health has developed a specialized kit that can detect tissue abnormalities.
LATEST
LATEST
Dalrada Health Products is pleased to announce it has reached an agreement with a large Mexican distributor to supply its GlanHealth products to healthcare facilities, commercial businesses, and consumers across Mexico.
Dalrada Portfolio Companies Poised To Address Coronavirus, Cervical Cancer And Reducing Co2 Emissions Worldwide In Q2, 2020
Dalrada files a provisional patent with the United States Patent and Trademark Office (USPTO) for their product designed to screen for cervical cancer.
Dalrada Health Products is pleased to announce it has reached an agreement with a large Mexican distributor to supply its GlanHealth products to healthcare facilities, commercial businesses, and consumers across Mexico.
Dalrada Portfolio Companies Poised To Address Coronavirus, Cervical Cancer And Reducing Co2 Emissions Worldwide In Q2, 2020
Advanced health products and services that meet the needs of global consumers.
INNOVATIVE
SOLUTIONS
CENTERED
GROWTH
FOCUSED
DALRADA
HEALTH PRODUCTS
Early detection and treatment can save countless lives.
In many developed countries, the annual incidence and mortality rates from cervical cancer have been reduced by 50-70% since the introduction of simple population-based screening.
Enabling safe, reliable, and early detection.
Based on the World Health Organization’s recommended procedure for conducting visual inspection with acetic acid(VIA), Dalrada Health has developed a specialized kit that can detect tissue abnormalities.
LATEST
NEWS & BLOGS
Dalrada Health Products is pleased to announce it has reached an agreement with a large Mexican distributor to supply its GlanHealth products to healthcare facilities, commercial businesses, and consumers across Mexico.
New appointment will strengthen the company's commitment to global care while signaling further expansion.
Dalrada Health Products is pleased to announce it has reached an agreement with a large Mexican distributor to supply its GlanHealth products to healthcare facilities, commercial businesses, and consumers across Mexico.
Dalrada Portfolio Companies Poised To Address Coronavirus, Cervical Cancer And Reducing Co2 Emissions Worldwide In Q2, 2020
Dalrada files a provisional patent with the United States Patent and Trademark Office (USPTO) for their product designed to screen for cervical cancer.
Company's revolutionary product will aid in health screenings and aims to detect early signs of cervical cancer.
